The Revenue for the quarter ended  March 2023 of Rs. 19390.48 millions grew by 8.60 % from Rs. 17855.44 millions.The Net Loss for the quarter ended March 2023 is Rs. -1374.69 millions as compared to Net Profit of Rs. 2055.97 millions of corresponding quarter ended March 2022OP of the company witnessed a marginal growth to 4506.36 millions from 3405.67 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 19390.48 17855.44 8.60 82206.62 81415.81 0.97 82206.62 81415.81 0.97
Other Income 2329.65 1789.82 30.16 9859.39 6146.28 60.41 9859.39 6146.28 60.41
PBIDT 4506.36 3405.67 32.32 24587.06 23028.49 6.77 24587.06 23028.49 6.77
Interest 588.60 740.10 -20.47 2068.16 2360.41 -12.38 2068.16 2360.41 -12.38
PBDT -2665.96 2665.57 -200.01 17560.22 24971.41 -29.68 17560.22 24971.41 -29.68
Depreciation 467.29 417.72 11.87 1841.48 1596.95 15.31 1841.48 1596.95 15.31
PBT -3133.25 2247.85 -239.39 15718.74 23374.46 -32.75 15718.74 23374.46 -32.75
TAX -1758.56 191.88 -1016.49 3631.05 3396.57 6.90 3631.05 3396.57 6.90
Deferred Tax -2605.10 -210.77 1135.99 -238.26 -714.21 -66.64 -238.26 -714.21 -66.64
PAT -1374.69 2055.97 -166.86 12087.69 19977.89 -39.49 12087.69 19977.89 -39.49
Equity 282.17 282.17 0.00 282.17 282.17 0.00 282.17 282.17 0.00
PBIDTM(%) 23.24 19.07 21.84 29.91 28.29 5.74 29.91 28.29 5.74

Glenmark Pharma Share Price

802.25 -25.80 (-3.12%)
22-Sep-2023 18:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1131.60
Dr. Reddys Lab 5516.35
Cipla 1186.60
Zydus Lifesciences 595.60
Lupin 1097.05
View more..